Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies
- PMID: 21814473
- PMCID: PMC3148068
- DOI: 10.3390/ph2030150
Mitochondrial Medicine and the Neurodegenerative Mitochondriopathies
Abstract
Neurodegenerative diseases are a common late-life scourge for which disease-modifying treatments are sorely needed. Mitochondrial perturbation is commonly observed in these diseases, so pursuing treatment development strategies that target mitochondria or processes affected by mitochondria seems reasonable. This review discusses the rationale underlying past and current efforts to treat neurodegenerative diseases using mitochondrial medicine, and tries to predict how future efforts might proceed.
Figures


References
-
- McKeith I.G., Galasko D., Kosaka K., Perry E.K., Dickson D.W., Hansen L.A., Salmon D.P., Lowe J., Mirra S.S., Byrne E.J., Lennox G., Quinn N.P., Edwardson J.A., Ince P.G., Bergeron C., Burns A., Miller B.L., Lovestone S., Collerton D., Jansen E.N., Ballard C., de Vos R.A., Wilcock G.K., Jellinger K.A., Perry R.H. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop. Neurology. 1996;47:1113–1124. - PubMed
-
- Swerdlow R.H. Treating neurodegeneration by modifying mitochondria: Potential solutions to a "complex" problem. Antioxid. Redox Signal. 2007;9:1591–1603. - PubMed
-
- Swerdlow R.H., Kish S.J. Mitochondria in Alzheimer's disease. Int. Rev. Neurobiol. 2002;53:341–385. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous